Cargando…

Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN

Detalles Bibliográficos
Autores principales: Stegelmann, Frank, Wille, Kai, Busen, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, Kolatzki, Vera, Döhner, Hartmut, Stadler, Rudolf, Döhner, Konstanze, Griesshammer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318877/
https://www.ncbi.nlm.nih.gov/pubmed/32616864
http://dx.doi.org/10.1038/s41375-020-0945-3
_version_ 1783730338109849600
author Stegelmann, Frank
Wille, Kai
Busen, Hannah
Fuchs, Christiane
Schauer, Stefanie
Sadjadian, Parvis
Becker, Tatjana
Kolatzki, Vera
Döhner, Hartmut
Stadler, Rudolf
Döhner, Konstanze
Griesshammer, Martin
author_facet Stegelmann, Frank
Wille, Kai
Busen, Hannah
Fuchs, Christiane
Schauer, Stefanie
Sadjadian, Parvis
Becker, Tatjana
Kolatzki, Vera
Döhner, Hartmut
Stadler, Rudolf
Döhner, Konstanze
Griesshammer, Martin
author_sort Stegelmann, Frank
collection PubMed
description
format Online
Article
Text
id pubmed-8318877
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83188772021-08-13 Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN Stegelmann, Frank Wille, Kai Busen, Hannah Fuchs, Christiane Schauer, Stefanie Sadjadian, Parvis Becker, Tatjana Kolatzki, Vera Döhner, Hartmut Stadler, Rudolf Döhner, Konstanze Griesshammer, Martin Leukemia Letter Nature Publishing Group UK 2020-07-03 2021 /pmc/articles/PMC8318877/ /pubmed/32616864 http://dx.doi.org/10.1038/s41375-020-0945-3 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Stegelmann, Frank
Wille, Kai
Busen, Hannah
Fuchs, Christiane
Schauer, Stefanie
Sadjadian, Parvis
Becker, Tatjana
Kolatzki, Vera
Döhner, Hartmut
Stadler, Rudolf
Döhner, Konstanze
Griesshammer, Martin
Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_full Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_fullStr Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_full_unstemmed Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_short Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_sort significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in bcr-abl1-negative myeloproliferative neoplasms (mpn) - on behalf of the german study group-mpn
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318877/
https://www.ncbi.nlm.nih.gov/pubmed/32616864
http://dx.doi.org/10.1038/s41375-020-0945-3
work_keys_str_mv AT stegelmannfrank significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT willekai significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT busenhannah significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT fuchschristiane significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT schauerstefanie significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT sadjadianparvis significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT beckertatjana significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT kolatzkivera significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT dohnerhartmut significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT stadlerrudolf significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT dohnerkonstanze significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT griesshammermartin significantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn